丁基4-氯丁基醚 | 4161-25-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 丁基4-氯丁基醚
• 英文名称: butyl 4-chlorobutyl ether
• 英文别名: 1-butoxy-4-chlorobutane；1-butoxy-4-chloro-butane；butyl-(4-chloro-butyl)-ether；Butyl-(4-chlor-butyl)-aether；1-Butoxy-4-chlor-butan；Butyl-(4-chlor-butyl)-ether
• CAS: 4161-25-5
• 化学式: C₈H₁₇ClO
• 分子量: 164.675
• InChiKey: IJEMZYKPFZPVAV-UHFFFAOYSA-N

物化性质

• 沸点：
  84 °C(Press: 13 Torr)
• 密度：
  0.923 g/cm3(Temp: 23 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  10
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  丁基4-氯丁基醚 、 sodium butanolate 生成 1,4-二丁氧基丁烷
  参考文献：
  名称：

  Rempp, Bulletin de la Societe Chimique de France, 1957, p. 844,846

  摘要：

  DOI：
• 作为产物：
  描述：

  4-丁氧基丁醇 在 吡啶 、 氯化亚砜 作用下， 生成 丁基4-氯丁基醚
  参考文献：
  名称：

  Rempp, Bulletin de la Societe Chimique de France, 1957, p. 844,846

  摘要：

  DOI：

文献信息

• Water-Soluble Calixarenes as New Inverse Phase-Transfer Catalysts. Their Scope in Aqueous Biphasic Alkylations and Mechanistic Implications
  作者：Shoichi Shimizu、Takashi Suzuki、Seiji Shirakawa、Yasuyuki Sasaki、Choichiro Hirai

  DOI：10.1002/1615-4169(200206)344:3/4<370::aid-adsc370>3.0.co;2-3

  日期：2002.6

  Alkylation reactions of active methylene compounds, alcohols and phenols with alkyl halides in aqueous NaOH solution can be carried out without the need for any added organic solvents in most cases. The water-soluble calix[n]arenes, which contain trimethylammoniomethyl groups on the upper rim, were used as inverse phase-transfer catalysts, resulting in the corresponding alkylated products in good to

  在大多数情况下，无需任何添加的有机溶剂即可在 NaOH 水溶液中进行活性亚甲基化合物、醇和酚与烷基卤化物的烷基化反应。水溶性杯[n]芳烃在上缘含有三甲基氨甲基，用作反相转移催化剂，得到相应的烷基化产物，产率从良好到高产率。讨论了该方法在水性双相烷基化反应中的范围和机理意义。
• Dimethyl sulfoxide as a solvent in the Williamson ether synthesis
  作者：Russel G. Smith、Alan Vanterpool、H. Jean Kulak

  DOI：10.1139/v69-325

  日期：1969.6.1

  prepared from sodium hydroxide, n-butyl alcohol, and n-butyl chloride using excess of the alcohol as solvent in 61% yield after 14 h reaction time. However, when the excess alcohol was replaced by dimethyl sulfoxide, the yield of ether rose to 95% with 9.5 h reaction time. Other primary alkyl chlorides exhibited similar behavior to n-butyl chloride, but secondary alkyl chlorides and primary alkyl bromides

  使用常规的威廉姆森醚合成法，使用过量的醇作为溶剂，从氢氧化钠、正丁醇和正丁基氯制备正丁醚，反应 14 小时后，产率为 61%。然而，当过量的醇被二甲亚砜代替时，乙醚的产率在 9.5 小时的反应时间内升至 95%。其他伯烷基氯表现出与正丁基氯相似的行为，但仲烷基氯和伯烷基溴几乎没有醚化作用，消除是主要反应。未反应的卤化物，如氯乙烯、溴化苯和 2,4-二硝基溴苯，在二甲亚砜中未醚化。从脂肪族二氯化物获得的反应产物取决于氯原子的相对位置。仲醇反应生成醚，但叔醇非常不活泼。多元醇通常会产生高产率的醚，主要产物是除一个羟基之外的所有羟基都被醚化的产物。你...
• Reaction of Alkyl Halides with Mercury(II) Salts in Tetrahydrofuran. A Facile Preparation of 4-Alkoxybutyl Acetates and Chlorides
  作者：Nanao Watanabe、Sakae Uemura、Masaya Okano

  DOI：10.1246/bcsj.49.2500

  日期：1976.9

  The reaction of primary and secondary alkyl iodides and bromides with Hg(OAc)2 and HgCl2 in tetrahydrofuran (THF) affords the THF-incorporated compounds (1), RO(CH2)4X [X=OAc and Cl, respectively], in good yields. When HgBr2 and aqueous or alcoholic Hg(ClO4)2 were used as mercury(II) salts, the yields of 1(X=Br, OH, and OR′) were low. Similar treatment with HgI2 gave scarcely any 1. A reaction scheme

  伯和仲烷基碘化物和溴化物与 Hg(OAc)2 和 HgCl2 在四氢呋喃 (THF) 中的反应得到掺入 THF 的化合物 (1)，RO(CH2)4X [X=OAc 和 Cl，分别]产量。当 HgBr2 和水或醇 Hg(ClO4)2 用作汞 (II) 盐时，1(X=Br、OH 和 OR') 的产率很低。用 HgI2 进行类似处理几乎没有得到任何 1。 提出了一种涉及 O-烷基四氢呋喃离子作为中间体的反应方案，用于形成 1。
• 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
  申请人：——

  公开号：US20030105098A1

  公开（公告）日：2003-06-05

  The present invention comprises 6-9-Disubstituted 2-[trans-(4-aminocyclohexyl]aminopurines that are useful in inhibiting cyclin dependent kinases, particularly cdk-2. The present invention also provides a method of preventing apoptosis in neuronal cells and a method of inhibiting the development of neoplasms.

  本发明涉及6-9-二取代的2- [转-（4-氨基环己基）]氨基嘌呤，其在抑制细胞周期依赖性激酶，特别是cdk-2方面具有用途。本发明还提供了一种预防神经细胞凋亡和抑制肿瘤发展的方法。
• 6, 9-disubstituted 2-&lsqb;trans-(4-aminocyclohexyl)amino&rsqb; purines
  申请人：Aventis Pharmaceuticals Inc.

  公开号：US06479487B1

  公开（公告）日：2002-11-12

  The present invention provides novel compounds of the formula (I) wherein R is selected from the group consisting of R2, R2NH—, or R3R4N—R5- wherein R2 is selected from the group consisting of C9-C12 alkyl, Z is selected from the group consisting of phenyl, heterocycle, cycloalkyl, and naphthanlene; and M is selected from the group consisting of hydrogen, C1-C4 alkyl, and wherein each C9-C12 alkyl or Z is optionally substituted with 1 to 3 substituents, which may be the same or different, and which are selected from the group consisting of D, E, wherein each D is independently selected from the group consisting of trifluoromethyl, trifluoromethoxy, and C1-C4 alkoxy; each E is independently selected from the group consisting of Hal, OH, and C1-C8 alkyl; R3 and R4 are selected from the group consisting of hydrogen, C1-C4 alkyl and (CH2)y-phenyl, wherein y is an integer 0-8, with the proviso that R3 and R4 not both be hydrogen; R5 is C1-C8 alkylene; and R1 is selected from the group consisting of cyclopentyl, cyclopentenyl and isopropyl, and the pharmaceutically acceptable salts, optical isomers, and hydrates thereof, with the proviso that when R2 is the group wherein n is 1 or greater; R1 is isopropyl or cyclopentyl; R6 is hydrogen, C1-C4 alkyl, or (CH2)m-phenyl; and Z is phenyl, heterocycle, or cycloalkyl, that Z is substituted with 1 to 3 substituents, which may be the same or different, and which are selected from the group consisting of In addition, the present invention provides a method of inhibiting cyclin dependent kinases, particularly cdk-2. The present invention also provides a method of preventing apoptosis in neuronal cells and a method of inhibiting the development of neoplasms.

  本发明提供了公式(I)的新化合物，其中R选自R2、R2NH-或R3R4N-R5-组成的群，其中R2选自C9-C12烷基，Z选自苯基、杂环、环烷基和萘基；M选自氢、C1-C4烷基和其中每个C9-C12烷基或Z可选择地被1-3个取代基取代，这些取代基可以相同也可以不同，选自D、E组成的群，其中每个D独立地选自三氟甲基、三氟甲氧基和C1-C4烷氧基；每个E独立地选自卤素、羟基和C1-C8烷基；R3和R4选自氢、C1-C4烷基和(CH2)y-苯基，其中y是0-8的整数，但R3和R4不能同时为氢；R5是C1-C8烷基；R1选自环戊基、环戊烯基和异丙基，以及其药学上可接受的盐、光学异构体和水合物，但当R2为n为1或更大的基团时；R1为异丙基或环戊基；R6为氢、C1-C4烷基或( )m-苯基；Z为苯基、杂环或环烷基，但Z被1-3个取代基取代，这些取代基可以相同也可以不同，选自此外，本发明提供了一种抑制细胞周期依赖性激酶，特别是cdk-2的方法。本发明还提供了一种预防神经细胞凋亡和抑制肿瘤发展的方法。